Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
(WorldNews Canada)

Sierra Oncology to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference - `Beyond PARP - Next Generation DDR Therapeutics` scheduled for 8:35 am ETon September 26, 2017- VANCOUVER, Sept. 20, 2017/CNW/ - Sierra Oncology, Inc. (NASDAQ: SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled `Beyond PARP - Next Generation DDR Therapeutics` at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York. The presentation is scheduled for...